• On April 4, 2005 Elekta acquired IMPAC Medical Systems, transforming Elekta into a comprehensive provider of systems and solutions across the whole spectrum of can-cer care. Acquisition value amounted to USD 257 M (SEK 1,812 M) • Profit after taxes amounted to SEK 241 M (248). Earnings per share after dilution amounted to SEK 7.67 (7.63). • Operating profit increased by 14 percent, amounting to SEK 349 M (306) and the operating margin was 11 percent (11). • Cash flow from operating activities amounted to SEK 408 M (448). • Order bookings rose 9 percent to SEK 3,558 M (3,262). At fixed exchange rates order bookings increased 12 percent. • Net sales increased 9 percent to SEK 3,152 M (2,900). At fixed exchange rates, net sales increased by 13 percent. • New financial objectives established for the Group, including an objective to achieve an operating margin of 14-16 percent not later than fiscal year 2007/08. • For the first time in 10 years, the Board is proposing a dividend. In accordance with Elekta's dividend policy, an ordinary dividend of SEK 1.60 per share is proposed and, in addition, an extraordinary dividend of SEK 5.00 per share.
For the full report, please see enclosed pdf file.